Skip to main content

Table 2 Clinical characteristics of Groups B, C, and D at 0 week

From: The expression of interleukin-1β in patients with chronic hepatitis B treated with pegylated-interferon-alpha combined with tenofovir disoproxil fumarate and monotherapy

Variables

Group B(n = 46)

Group C(n = 39)

Group D(n = 32)

P value

Age (year)

40(34,48.3)

39(29,46)

41.5(31,49.8)

0.499

Gender

    

Male n (%)

26(56.5)

28(71.8)

17(53.1)

0.21

Female n (%)

20(43.5)

11(28.2)

15(46.9)

Family history of hepatitis B

    

Yes n (%)

15(32.6)

8(20.5)

12(37.5)

0.262

No n (%)

31(67.4)

31(79.5)

20(62.5)

  1. Values are expressed as medians (IQR) or counts (%) as appropriate